Biomimetic Model of Tumor Microenvironment on Microfluidic Platform

Area of Science:

• Oncology
• Biomedical Engineering
• Cell Biology

Background:

• The tumor microenvironment (TME) is crucial for cancer progression, drug resistance, and recurrence.
• Current research limitations stem from a lack of experimental tools to study intricate TME interactions.
• Systematic understanding of the TME is essential to overcome cancer treatment challenges.

Purpose of the Study:

• To develop a biomimetic in vitro model of the tumor microenvironment (TME) using microfluidics.
• To enable comprehensive study of interactions between TME constituents.
• To investigate paracrine signaling, angiogenesis, and lymphangiogenesis within the TME.

Main Methods:

• Utilized a microfluidic platform to create a biomimetic TME model.
• Co-cultured tumor cell lines (SK-OV-3, MKN-74, SW620) with primary fibroblasts.
• Incorporated varying extracellular matrix compositions.
• Observed tumor cell morphology, angiogenesis, and lymphangiogenesis.

Main Results:

• Demonstrated significant tumor cell morphological changes influenced by fibroblast co-culture and extracellular matrix composition.
• Enabled direct observation of angiogenesis induced by tumor-stroma interactions.
• Successfully reconstituted simultaneous angiogenesis and lymphangiogenesis within the biomimetic model.

Conclusions:

• The developed microfluidic biomimetic model provides a powerful tool for studying complex TME biology.
• This platform facilitates a deeper understanding of TME interactions, potentially informing new cancer therapies.
• The experimental approach offers insights into mechanisms of drug resistance and cancer recurrence.